National HTA methods and process guidelines (hereon in referred to as HTA guidelines) have been identified as a key factor in establishing a well-functioning HTA system (1,2). A number of resources already exist for countries seeking to develop their own HTA guidelines, such as the Practical Guide on Evidence-Informed Deliberative Processes, the iD

The rapidly evolving healthcare landscape is being shaped by cutting-edge technologies such as big data analytics, digital advancements, and genomics, leading to the emergence of Precision Medicine (PM). National genomics programs worldwide are embracing PM\'s potential, signaling an imminent integration into healthcare systems. However, PM interve

The Thai healthcare system faces pressure to fund high-cost new branded pharmaceuticals. Paying more may encourage innovation with positive implications for future population health, but it also means less money is available to fund other healthcare with negative implications for current population health. Recent work in the UK estimated, for the f

Before the pandemic, many countries recognized the importance of regional collaboration in preparing for future pandemics, whether within ASEAN or the broader Asua Pacific region. In 2019, the SSHSPH discussed with the DFAT Australia for funding and support to this initiative, and the onset of the pandemic provided the impetus for it to move forwar

\"UNITE for Thailand\" is an initiative designed to cultivate the next generation of global health leaders, anchored by the Health Intervention and Technology Assessment Program (HITAP). The proposal acknowledges the critical role of effective leadership in addressing global health challenges and emphasizes the need for proactive support for early

65083001HM008L0ConvergeDH,Digital Health,Health Information System (HIS),Health Information Systems

Digital health and Health Information Systems (HIS) are dramatically altering the landscape for health. Thailand achieved Universal Health Coverage (UHC) in 2002. However, the delivery of health services relies heavily on manpower without digitisation, and the COVID-19 pandemic has exposed the lack of adequate digital health platforms in the countr

The objective of this study is to estimate the cost-utility analysis of the cholinesterase inhibitors (i.e., donepezil, galantamine and rivastigmine) compared with no drug treatment in patients with mild to moderate alzheimer’s disease (AD) in Thailand based on the societal and governmental perspectives and to estimate the budget impact of the ch

Presently, Cost-Effectiveness Analysis has been increasingly adopted in health technology assessment. In addition, it is recognized as an important tool for policy makers in the health care resource allocation decision making process. However, the presentation of Cost-Effectiveness Analysis results in terms of cost per Quality-Adjusted Life Year (Q